Robert Discordia
Co-Founder & CEO at Equulus Therapeutics
- Role
- Co-founder, President & CEO at Equulus Therapeutics
- Location
- Raleigh, NC, US
- LinkedIn followers
- 500 followers
About Robert Discordia
Biotech Drug Development Strategist & Leader with success designing and executing operational and strategic growth initiatives. Design, build and lead R&D and advance discovery compounds to achieve \"first-in-human dosing\" in record times and dramatically lower costs. Senior team member active in originating and managing fundraising efforts and driving high-profile negotiations.Therapeutic area development agnostic with significant experience in development of Oncology, Immunooncology, Immunology, Inflammation, Fibrosis, CNS, Neurology, and Anti-viral.Pharmaceutical successes at AVANZARX, CORBUS, and BRISTOL MYERS SQUIBB include:§ PROGRAM-CENTRIC LIQUIDITY THESIS / VIRTUAL MODEL (Avanzarx): Created model to discover/develop therapeutic assets exclusively for established pharma providing high IRR using total virtual biotech model relying on external service providers (no fixed asset costs).§ PRE-CLINICAL DEVELOPMENT MODEL (Corbus): Implemented integrated development model for pre-clinical assets to achieve first human dose in < 1 year and reduce overall cost of phase by 35% from prior model.§ VARIABLIZATION OF API MANUFACTURING, 2017 (BMS): Led corporate-level transformation delivering $Multi-TenMillion in direct, cost avoidance, and product cost reduction savings.§ SUPPLIER CONSOLIDATION / RENEGOTIATION (BMS): Consolidated manufacturing supplier network and renegotiated supply contracts delivering $Multi-TenMillion savings - 7.0% reduction.§ RECOGNITION- Conference Keynote Speaker/Presenter - 45+ Peer Reviewed Articles - 17 Patents & Applications - Small Molecules - Oligopeptides & Other Non-Traditional Small Molecules - Antibody Drug Conjugates - Vitamin Drug Conjugates - Traditional & Non-Traditional Formulation Approaches - CMC Expert - In/Out Licensing - Intellectual Property/Patents - Global External Suppliers in CRO/CMO/CDMO Industry - Outsourcing for Virtual & Semi-Virtual Biotechs and Established Pharma
Experience
Co-founder, President & CEO
Oct 2023 — Present · Charlotte, NC, US
Education
Scripps Research
Post Doctoral, Organic Chemistry
Syracuse University
Ph.D., Organic Chemistry
State University of New York Cortland
BS, Chemistry
Skills
- Management
- Pharmaceutical Process Development
- Business Development
- Gmp
- Pharmaceutical Research
- Validation
- Cross-Functional Team Leadership
- Pharmaceuticals
- Cgmp
- Strategic Partnerships
- Formulation Development
- Process Chemistry
- Six Sigma
- Chemistry
- Pharmaceutical Industry
- Chemical Engineering
- Pharmaceutical Development
- Process Validation
- Lc-Ms
- Life Sciences
- R&D
- Clinical Development
- Cmc Development
- Procurement
- Outsourcing
- Drug Development
- Biopharmaceuticals
- Biotechnology
- Process Research
- Research and Development (R&D)
- Lean Six Sigma
- Product Development
- Technology Transfer
- Pharmaceutics
- Organic Synthesis
- Organic Chemistry
- Manufacturing
- Formulation
- Strategy
- Quality by Design
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.